中国医药市场的价格控制与意大利医药市场的对比研究

发布时间：2018-03-17 22:14

本文选题：价格控制　切入点：医药市场　出处：《复旦大学》2013年硕士论文　论文类型：学位论文

【摘要】：由于表现出特别的特性,药品市场一直是一个独一无二的市场,脆弱而无序。要想理解医药市场的动态性,我们需要结合该行业的具体特点来进行分析。这个市场最为基本的一个特点就是：市场的产品与人的生命健康息息相关。这一特点凸显了作为一个有价值的物品,药品对于消费者的重要性。因此,药品的质量和安全更需要得到保证。医药市场的另一个特点就是对药品的需求,而这需求是医生创造的(并非消费者自己)。因此,在这个市场中,消费者并非具有选择产品的自由。所以,对于政策的制定者有一点十分重要：要将消费者、医生和市场本身的行为结合进行充分的考虑。在中国,经济的发展和逐步冒进的医疗改革仍然有着各种各样的问题,如监督的缺失、不完善的补偿机制。随之而来的是医生乱开处方的现象、无序的供给分配系统和严重过高的药价。事实上,在中国昂贵的医药开支一直是民众抱怨的焦点。在意大利有一个不同的医药体系,一种由国家支出的全民医保,能够向在这个体质之内的病人提供付得起的或者免费的医药。意大利在医药监管方面的经验也许能够成为中国政策制定者们提供一些有益的借鉴。鉴于以上探索,世界上人口最多的国家将会如何处理高药价的问题?这篇论文着重介绍了中国复杂的医药供给链,重点关注了药价控制办法失效的原因。最终,这项研究提供了意大利系统和框架进行比较和思考,以对当前实施的医改有更多的思考。本论文采用的研究方法为文献回顾,理论分析。文中数据来自于中国政府官方网站和一些网上的电子期刊、报纸。
[Abstract]:Because of its special characteristics, the pharmaceutical market has always been a unique market, fragile and disordered. To understand the dynamics of the pharmaceutical market, We need to analyze it in the light of the specific characteristics of the industry. One of the most fundamental features of this market is that the products of the market are closely related to human life and health. The importance of drugs to consumers. Therefore, the quality and safety of medicines need more assurance. Another characteristic of the pharmaceutical market is the demand for drugs, which is created by doctors (not the consumers themselves). In this market, consumers do not have the freedom to choose products. So it is important for policy makers to take full account of the actions of consumers, doctors and the market itself. In China, the development of the economy and the progressive reform of medical care still have a variety of problems, such as the lack of supervision, the imperfect compensation mechanism, and the phenomenon of doctors prescribing prescriptions indiscriminately. Disorderly supply distribution systems and severely exorbitant drug prices. In fact, expensive spending on medicines in China has been the focus of public complaints. There is a different medical system in Italy, a universal health care system funded by the state. To be able to provide affordable or free medicine to patients in this physical condition. Italy's experience in medicine regulation may provide some useful lessons for Chinese policymakers. In the light of the above exploration, how will the world's most populous country deal with the problem of high drug prices? This paper focuses on the complex pharmaceutical supply chain in China, focusing on the reasons for the failure of drug price control methods. Finally, the study provides a comparison and reflection between Italian systems and frameworks. In order to the current implementation of health care reform has more thought. The research methods used in this paper are literature review and theoretical analysis. The data in this paper are from the official website of the Chinese government and some online electronic journals and newspapers.
【学位授予单位】：复旦大学
【学位级别】：硕士
【学位授予年份】：2013
【分类号】：F426.72;F454.6

【相似文献】